Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Repurposed prophylaxis strategies for COVID-19: a review

Erwan Sallard, François-Xavier Lescure, Charles Burdet, Jérémie Guedj, Yazdan Yazdanpanah, Nathan Peiffer-Smadja
doi: https://doi.org/10.1101/2020.05.30.20117937
Erwan Sallard
1École Normale Supérieure de Paris, 45 Rue D’Ulm, 75005, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
François-Xavier Lescure
2Université de Paris, IAME, INSERM, F-75018, Paris, France
3Department of Infectious and Tropical Diseases, Assistance Publique – Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, 75018, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Burdet
2Université de Paris, IAME, INSERM, F-75018, Paris, France
3Department of Infectious and Tropical Diseases, Assistance Publique – Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, 75018, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jérémie Guedj
2Université de Paris, IAME, INSERM, F-75018, Paris, France
3Department of Infectious and Tropical Diseases, Assistance Publique – Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, 75018, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yazdan Yazdanpanah
2Université de Paris, IAME, INSERM, F-75018, Paris, France
3Department of Infectious and Tropical Diseases, Assistance Publique – Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, 75018, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan Peiffer-Smadja
2Université de Paris, IAME, INSERM, F-75018, Paris, France
3Department of Infectious and Tropical Diseases, Assistance Publique – Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, 75018, Paris, France
4National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: n.peiffer-smadja@imperial.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction Efficient therapeutic strategies are needed to counter the COVID-19 pandemic, caused by the SARSCoV-2 virus. In a context where specific vaccines are not yet available, the containment of the pandemic would be facilitated with efficient prophylaxis.

Methods We screened several clinical trials repositories and platforms in search of the prophylactic strategies that are investigated against COVID-19 in late April 2020.

Results Up to April 27, 2020, we found 68 clinical trials targeting medical workers (n = 43, 63%), patients relatives (n = 16, 24%) or individuals at risk of severe COVID-19 (n = 5, 7%). (Hydroxy)chloroquine was the most frequently evaluated treatment (n = 46, 68%), before BCG vaccine (n = 5, 7%). Sixty-one (90%) clinical trials were randomized with a median of planned inclusions of 600 (IQR 255–1515).

Conclusion The investigated prophylaxis strategies cover both pre- and post-exposure prophylaxis and study numerous immune enhancers and antivirals, although most research efforts are focused on (hydroxy)chloroquine.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funding was received for this study.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No ethics approval is required for systematic reviews.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data used in this article stems from registered clinical trials and is summarised in the supplementary table.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted June 03, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Repurposed prophylaxis strategies for COVID-19: a review
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Repurposed prophylaxis strategies for COVID-19: a review
Erwan Sallard, François-Xavier Lescure, Charles Burdet, Jérémie Guedj, Yazdan Yazdanpanah, Nathan Peiffer-Smadja
medRxiv 2020.05.30.20117937; doi: https://doi.org/10.1101/2020.05.30.20117937
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Repurposed prophylaxis strategies for COVID-19: a review
Erwan Sallard, François-Xavier Lescure, Charles Burdet, Jérémie Guedj, Yazdan Yazdanpanah, Nathan Peiffer-Smadja
medRxiv 2020.05.30.20117937; doi: https://doi.org/10.1101/2020.05.30.20117937

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (227)
  • Allergy and Immunology (500)
  • Anesthesia (110)
  • Cardiovascular Medicine (1227)
  • Dentistry and Oral Medicine (205)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (528)
  • Epidemiology (10001)
  • Forensic Medicine (5)
  • Gastroenterology (497)
  • Genetic and Genomic Medicine (2443)
  • Geriatric Medicine (236)
  • Health Economics (479)
  • Health Informatics (1635)
  • Health Policy (751)
  • Health Systems and Quality Improvement (633)
  • Hematology (247)
  • HIV/AIDS (530)
  • Infectious Diseases (except HIV/AIDS) (11855)
  • Intensive Care and Critical Care Medicine (625)
  • Medical Education (251)
  • Medical Ethics (74)
  • Nephrology (267)
  • Neurology (2272)
  • Nursing (139)
  • Nutrition (349)
  • Obstetrics and Gynecology (451)
  • Occupational and Environmental Health (532)
  • Oncology (1244)
  • Ophthalmology (375)
  • Orthopedics (133)
  • Otolaryngology (226)
  • Pain Medicine (154)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (729)
  • Pharmacology and Therapeutics (311)
  • Primary Care Research (281)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4823)
  • Radiology and Imaging (833)
  • Rehabilitation Medicine and Physical Therapy (488)
  • Respiratory Medicine (650)
  • Rheumatology (283)
  • Sexual and Reproductive Health (237)
  • Sports Medicine (224)
  • Surgery (266)
  • Toxicology (44)
  • Transplantation (124)
  • Urology (99)